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ABSTRACT  
 
Background: Growing evidence suggests that brain white matter changes and 
depressive symptoms are directly linked along the causal pathway.  The authors 
investigated whether baseline severity of brain white matter changes predict longer 
term future depressive outcomes in a community sample of non-disabled older adults. 
 
Method: In the Leukoaraiosis And Disability (LADIS) study, a longitudinal 
multicentre pan European study, 639 older subjects underwent baseline structural 
MRI and clinical assessments. Baseline severity of white matter changes was 
quantified volumetrically.  Depressive outcomes were assessed in terms of depressive 
episodes and depressive symptoms, as measured by score on the Geriatric Depression 
Scale. Subjects were clinically reassessed annually for up to three years.  Regression 
models were constructed to determine if severity of white matter changes at baseline 
predicted future depressive outcomes, after controlling for confounding factors. 
 
Results: Baseline severity of white matter changes independently predicted 
depressive symptoms at both two (p<0.001) and three years (p=0.015). Similarly, 
white matter changes predicted incident depression (p=0.02). Over the study period 
the population became significantly more disabled (p<0.001). When the regression 
models were adjusted to account for the influence of the prospective variable 
transition to disability, baseline white matter changes severity no longer predicted 
depressive symptoms at three years (p=0.09) or incident depression (p=0.08).  
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Conclusions: Our results support the vascular depression hypothesis and strongly 
implicate white matter changes in the pathogenesis of late life depression. 
Furthermore the findings indicate that, over time, part of the relationship between 
white matter changes and depression may be mediated by a loss of functional activity. 
Management strategies should be directed at reducing disability as well as tighter 
control of vascular risk factors and symptomatically treating depression. 
 
 
<273 words>
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INTRODUCTION 
It is generally assumed that brain white matter changes on MRI represent a surrogate 
marker for vascular damage and are involved in the pathogenesis of depression in 
older adults (Alexopoulos, 2006, Blazer and Hybels, 2005, Scheltens et al., 2003). 
Cross sectional studies have demonstrated a strong association between depressive 
symptoms and white matter changes, in particular frontal pathology  (de Groot et al., 
2000, Firbank et al., 2004, MacFall et al., 2001). Outcome studies have shown that 
white matter changes are associated with worsening clinical course, poorer treatment 
response and increased mortality (Baldwin et al., 2004, Levy et al., 2003, O'Brien et 
al., 1998). Finally, longitudinal studies suggest baseline severity of white matter 
changes may independently predict future depressive outcomes (Godin et al., 2008). 
Taken together these findings support the vascular depression hypothesis which 
proposes that frontostriatal dysfunction as a result of vascular damage predisposes, 
precipitates and perpetuates depressive symptoms in older adults (Krishnan et al., 
1997). 
 
The LADIS (Leukoaraiosis and Disability in the Elderly) study is a large multi centre 
pan-European three year longitudinal study of initially non-disabled elderly subjects 
which investigates the relationship between white matter changes and subsequent 
development of disability and depressive symptoms. We have previously reported on 
cross-sectional associations in the baseline sample (Firbank et al., 2005, O'Brien et al., 
2006) and longitudinal results in a relatively non-disabled  population at short term 
(one year) follow-up (Teodorczuk et al., 2007).  
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In this report we examine the role of white matter changes as an independent predictor 
of both depressive outcomes in the longer term (at two and three years). The main 
hypothesis was that severity of white matter changes at baseline would be 
significantly and independently associated with the development of depressive 
outcomes at both two and three year follow-up, even after adjusting for the 
contribution of potential confounders.  
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METHOD 
 
Sample 
639 subjects were recruited between July 2001 and January 2003 from the 11 
European centres participating in the LADIS study (Amsterdam, Copenhagen, 
Florence, Graz, Göteborg, Helsinki, Huddinge, Lisboa, Mannheim, Newcastle upon 
Tyne and Paris). Most were recruited having presented to centres with mild cognitive 
disturbances (N=168), minor stroke (N=122), gait disturbances (N=28), psychiatric 
complaints (N=13) or other neurological disturbances (N=129). Further recruited 
subjects included those in whom white matter changes were incidentally found on 
structural neuroimaging taken in other clinical settings (N=107). Lastly, controls who 
were found to have white matter changes were recruited from other studies (N=72).  
 
At entry subjects were included if they were: 1) aged between 65 and 84; 2) living in 
the community; 3) non-disabled as assessed by the Instrumental Activities of Daily 
Living (IADL) scale (no impairment at all or only one item compromised) (Lawton 
and Brody, 1969); 4) accompanied by an informant; and 5) found to have any degree 
of age-related white matter changes (ARWMC) on MRI scan, from mild to severe 
according to categorization into the three severity classes of a revised version of the 
Fazekas scale (Fazekas et al., 1987). 
 
Subjects were excluded if they had either: 1) the presence of severe illnesses 
(e.g.cardiac, hepatic, renal failure, neoplastic or other relevant systemic disease) 
which would increase the likelihood of drop-out; 2) severe unrelated neurological 
diseases; 3) leukoencephalopathies revealed by brain imaging that turned out to be of 
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non-vascular origin (immunologic, demyelinating, metabolic, toxic or infectious); and 
4) severe psychiatric disorders.  
 
All procedures were explained to subjects who gave written consent to participate. 
Further details on design of the LADIS study have been previously reported (Pantoni 
et al., 2005).  
 
MRI acquisition 
Subjects had a baseline MRI scan at their respective centres. All centres used MRI 
systems with a field strength of 1.5T, apart from one centre which had a 0.5T system. 
A standard protocol was used (Pantoni et al., 2005). For the white matter rating, a 
FLAIR sequence was acquired with the following parameters:  FOV 250 mm, 
256x256 or 256x192 matrix, 5mm slice thickness, 0.5 mm slice gap, 19-28 slices, TE 
100-140 ms, TR 6000-10000 ms, TI 2000-2500 ms, echoes per shot 7-24. Volumetric 
analysis was performed by a single rater in Amsterdam on a Sparc 5 workstation 
(SUN, Palo Alto, California) (van Straaten et al., 2006). No distinction was made 
between subcortical and periventricular white matter changes. Areas of white matter 
changes around infarcts and lacunes were disregarded. 
 
Major steps in determining ARWMC by the operator were as follows: 1) lesions were 
marked using a ‘‘seed’’ and local thresholding was performed on each slice using 
home-developed software (Show Images, version 3.6.1 using a Canay-filter); 2) 
lesions were delineated and the total surface of the outlined area was calculated; and 
3) total volume of ARWMC was established by multiplying with the interslice 
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distance. Further details of the quantification process are described elsewhere (Gouw 
et al., 2006). 
 
Assessment of depressive outcomes 
Depressive symptoms were assessed by the self completed 15-item Geriatric 
Depression Scale (GDS). The GDS is a self reported questionnaire specifically 
developed as a screening instrument for the presence of depressive symptoms in older 
populations (Yesavage, 1988). The maximum possible score is 15. Depressive 
symptoms were assessed at baseline as well as one, two and three years. 
 
A history of depression was recorded, along with the date of any incident depression. 
History of depression was defined as a past medical history for a depressive episode 
requiring treatment or hospital admission. Incident depression was defined as any 
depressive episode requiring treatment or hospital admission over the course of the 
study. Both history and incident depression were obtained through subject interview 
and evaluation of the case notes. 
 
Assessment of potential mediators or confounders 
All subjects had a comprehensive baseline demographic and clinical assessment 
administered by trained personnel. Information was collected on age, gender, 
education, occupational status, living conditions, previous medical conditions 
including stroke (as defined according to World Health Organisation (Hatano, 1976)) 
and hypertension (Chalmers et al., 1999), prescribed medication, lifestyle habits 
(alcohol and smoking) and vascular risk factors. 
 
WHITE MATTER CHANGES AND DEPRESSIVE SYMPTOMS 
 10 
Further baseline assessments administered were as follows: 
1. Functional status in terms of disability as measured by means of IADL. This is 
a scale developed to monitor function and independent living amongst older 
adults and measures a broad set of daily activities including shopping for 
personal items, preparing meals, performing housework and managing 
personal finances (Lawton and Brody, 1969). 
2. Functional status in terms of the Disability Assessment for Dementia Scale 
(DAD).  This is a 40 item questionnaire that includes basic items of living 
(Gelinas et al., 1999).  
3. Mini mental state examination (MMSE) to assess cognition (Folstein et al., 
1975). 
4. Standard neurological and cardiovascular examination. 
 
Subjects were re-evaluated at one, two and three years. Transition to disability was 
defined as the change from none or one to at least two impaired IADL items. To 
increase reliability investigators were issued with a specifically designed handbook 
which contained guidelines for applying tools. A test of the interrater, intercenter 
reliability of IADL scoring showed good agreement in ratings of each scale item ( Κ 
statistic ranging from 0.69 to 0.85) (Inzitari et al., 2007). 
 
 
Statistical analysis 
Data was collected in each centre and entered into a central electronic database on a 
specifically developed website (www.unifi.it/LADIS). In a community dwelling 
population it is normal for depression rating scales to be heavily skewed towards low 
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values. Hence, for analysis we divided our data into quintiles, using the same GDS 
range for each quintile as in our previous study (O'Brien et al., 2006). For the 
ARWMC volumes, a logarithmic transform was used to produce normally distributed 
data.  
 
A two stage “step forward” regression analysis was used to determine the independent 
contribution of potential predictors of depressive outcomes. Initially, a univariate 
analysis was constructed to examine correlations between predictor variables and 
depressive symptoms at two and three years, the target variables. Baseline predictor 
variables included age, sex, baseline depressive symptoms (GDS), history of 
depression, educational level, smoking status, cognition (MMSE), history of stroke, 
hypertension and log ARWMC volume. As depressive symptoms (as measured by 
GDS) are on an ordinal (i.e. ordered, but not linear) scale, we used a Spearman rank 
order correlation coefficient (Rho) to determine the correlation. 
 
Variables which correlated significantly were then entered in a stepwise forward 
method into a multivariate analysis to determine the independent contribution of each 
predictor variable. As well as an ordinal logistic regression model of predictors of 
quintile of depression scale score at two and three years, a further binary logistic 
regression was performed to compare predictors of incident depression over the study 
period.  
 
In order to examine potential mechanisms by which white matter changes might 
depress mood, the prospective variable, transition to disability was included as an 
additional predictor variable in further models.   
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The significance level was set at P<0.05. 
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RESULTS 
Of the original 639 subjects, 501 subjects completed second year assessments and 440 
subjects completed final assessments, representing an attrition rate of approximately 
31% over the three years. Complete data were obtained from 399 subjects. Attrition 
resulted from subject drop out (N=73), missing data (N=124) and death (N=43). 
Baseline ARWMC, GDS and age were significantly higher in those without, as 
compared to those with, follow up data (ARWMC: median 15.5 vs. 13.3 ml; p=0.043 
Mann Whitney; GDS median 3 vs. 2; p <0.001, age 75.0 vs. 73.6 p 0.001).  
 
Table 1 summarises the key characteristics of the subjects who completed all final 
year assessments.  
 
Table 1 
 
 
As expected for a community population the group GDS score remained stable over 
time. The mean GDS score was 2.86 at baseline and 2.96 at 3 year; paired t test found 
no significant change in GDS over the study (t = -0.8, P= 0.4). 85 subjects had at least 
one depressive episode during the study time period.  
 
Cognition declined over the three years. The mean MMSE score was 27.85 (sd 2.2) at 
baseline and 27.11 (sd 3.5) at 3 year; paired t test found a significant change over the 
study (t = 4.9, P<0.001).  
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Over the study period the population became more disabled (table 2). Repeated 
measure ANOVA showed a significant difference over the three years (F=22; 
p<0.001). 68 subjects were classed as having made a transition to disability at two 
years and 95 at three years.  
 
Table 2 
 
 
 
Table 3 shows the results of the stepforward analysis of predictors of two year GDS. 
On univariate analysis log ARWMC volume, baseline GDS, cognition (MMSE) and 
years of education significantly correlated with depressive symptoms at two years. 
When these variables were entered into the multiple regression model, only baseline 
log ARWMC volume and baseline GDS remained predictive of depressive symptoms.  
 
Table 3 
 
 
Table 4 shows the results of the stepforward analysis of predictors of three year GDS 
Again, only baseline GDS and log ARWMC volume significantly and independently 
predicted quintile GDS at three years in the multivariate analysis. Sex, years of 
education and MMSE were no longer significant. 
 
Table 4 
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A binary regression model was undertaken to investigate the relationship between 
white matter changes and incident depression (Table 5). In the regression model, 
including all the significant correlators from the univariate analysis, only log 
ARWMC volume and history of depression independently predicted depressive 
episodes over the three years. 
 
Table 5 
 
In order to examine the influence of disability, further regression models were 
constructed including in the analysis the prospective variable, transition to disability. 
Baseline white matter changes severity continued to significantly and independently 
predict two year depressive symptoms in the new model (OR= 1.49 (CI: 1.24 –1.8) 
p<0.001). However, severity of white matter changes no longer independently 
predicted 3 year GDS (OR = 1.17 ( 0.97-1.4); p = 0.09) or incident depression over 
the study period (OR = 1.27 (0.97-1.65); p=0.08).  Transition to disability predicted 
both 3 year GDS (OR=2.11 (1.31-3.39); p=0.002) and 3 year incident depression 
(OR=2.16 (1.17-4) p=0.012) but failed to predict GDS at 2 years (OR = 1.3 (0.76-
2.225) p=0.3).  
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DISCUSSION 
The main result of this pan European study is that baseline severity of white matter 
changes in a non-disabled community population, independently and significantly 
predicts depressive episodes as well as depressive symptoms at both two and three 
years. Though MMSE and years of education are correlated with GDS in the 
univariate analysis, they do not predict depressive scores in the logistic regression 
models. As expected, baseline GDS score significantly predicted future depressive 
symptoms. 
 
These results not only build on our previous finding that baseline severity of white 
matter changes predicts one year depressive symptoms (Teodorczuk et al., 2007), but 
also demonstrate that such pathology is predictive of the clinically more meaningful 
depressive episodes. In the shorter study we were unable to demonstrate such an 
effect, potentially because of the relatively small number of depressive episodes over 
the one year period. 
 
On further analysis, when the prospective variable transition to disability is included 
in the regression model, severity of white matter changes continues to significantly 
predict GDS at two but not three years. Furthermore, in the new analysis white matter 
changes severity at baseline no longer predicts incident depression. These findings 
demonstrate that the independent effect of white matter changes on mood weakens 
with time as the community population becomes more disabled.  One possible 
explanation of our findings would be that, in the more disabled three year population, 
transition to disability is also a driver of depressive outcomes and so mediates the 
effect of the other significant covariates from the univariate analysis. Another 
WHITE MATTER CHANGES AND DEPRESSIVE SYMPTOMS 
 17 
explanation would be that disability and depression are both so strongly associated 
with white matter changes that it is difficult to determine causality using regression 
techniques. 
 
Other community studies have investigated the longitudinal relationship between 
white matter changes and late life depression. Recently, the 3C Dijon study found that 
severity of white matter changes independently predicts future risk of incident 
depression, however the influence of transition to disability was not specifically 
examined (Godin et al., 2008). In line with our results the large Cardiovascular Health 
study found that, after controlling for functional impairment, total severity of white 
matter changes no longer independently predicts future depressive symptoms 
(Steffens et al., 2002).  Lastly the PROSPER study found no longitudinal associations 
over three years between white matter changes and depressive outcomes in an age and 
sex adjusted logistic regression model (Versluis et al., 2006). However there were low 
levels of depressive symptoms in the PROSPER population which, together with low 
ARWMC volume of subjects, may have led to negative results.   
 
Previous reports from the LADIS study that severity of white matter changes predicts 
disability provide an interesting insight into the potential mechanisms which lead to 
depression (Inzitari et al., 2007). It is already known that a mutually reinforcing 
reciprocal relationship exists between disability and depressive symptoms in late life 
(Ormel et al., 2002); disability not only predicts depression but is also a consequence 
of depression. Taken together with our findings it is conceivable that white matter 
changes, in part, leads to a worsening in functional ability and an amplification loop 
may then be set up in the more disabled population, as the transition to disability leads 
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to depressive symptoms which in turn worsens functional ability. Thus, in the more 
disabled third year population, the relative influence of a potential indirect pathway 
mediated by disability may become greater and the independent contribution of white 
matter changes on depressive outcomes declines.  
 
Clinically, the value of this study lies in developing our understanding of the 
evolution of depression and the further implications concerning potential treatment 
strategies. Importantly, our results suggest a need for tighter control of vascular risk 
factors; firstly because of the strong independent effect of white matter changes on 
depressive outcomes and secondly, because white matter pathology is an independent 
predictor of disability (Inzitari et al., 2007). Furthermore, as a consequence of putative 
indirect mechanisms, whereby vascular damage may depress mood, rehabilitation 
based strategies targeted at improving functional abilities may prove beneficial in the 
prevention and treatment of late life depressive illnesses.  
 
The strengths of the study are the large, multicentre, pan European design and the size 
of the population, together with its relatively heterogeneous composition, all of which 
increase the generalisability of the findings. Further strengths include measurement of 
all scans by a single operator and the use of a volumetric scale which is less operator 
dependent and less susceptible to ceiling effects (van Straaten et al., 2006). 
 
The limitations are firstly, attrition over the three years makes it possible that the data 
may reflect methodological problems rather than a real effect. However our attrition 
rate is not uncommon for studies of this magnitude. Furthermore, the fact that those 
who were lost to follow up had a greater degree of white matter changes and 
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depressive symptoms make any effect seen in subsequent analyses more impressive. 
Secondly, GDS gives an indication of depressive symptoms over the past week, thus 
it may not capture the phenomenon under investigation. However, we used two 
depressive outcomes and found the results to be complimentary, suggesting we are 
observing a real effect. Thirdly, arguably some of the symptoms measured on GDS 
may actually represent a dysexecutive syndrome. Although this may be possible, it is 
becoming increasingly clear that, in older adults, depression is as much a cognitive 
disorder as a mood disorder and thus such overlapping symptomatology will always 
occur (Steffens and Potter, 2008). Lastly, we may have underestimated the number of 
cases of depression over the study as a result of our definition of incident depression, 
“a depressive episode requiring treatment or hospital admission”. However this 
limitation makes a type II error more likely and the fact that we demonstrate 
significant results over three years suggests validity of the study has not been 
compromised.    
 
Future research should be directed at determining the influence of progression in 
white matter changes on future depressive outcomes. In addition the findings from 
other longitudinal studies using complementary neuroimaging techniques, such as 
diffusion tensor imaging, should be linked, in order to develop an integrated 
perspective of the complex pathways that lead to depressive illnesses in later life 
(Kumar and Ajilore, 2008). 
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APPENDIX. List of participating centres and personnel.  
Helsinki, Finland (Memory Research Unit, Department of Clinical Neurosciences, 
Helsinki University): Timo Erkinjuntti, MD, PhD, Tarja Pohjasvaara, MD, PhD, Pia 
Pihanen, MD, Raija Ylikoski, PhD, Hanna Jokinen, LPsych, Meija-Marjut 
Somerkoski, MPsych, Riitta Mäntylä, MD, PhD, Oili Salonen, MD, PhD; Graz, 
Austria (Department of Neurology and MRI Institute, Medical University Graz): 
Franz Fazekas, MD, Reinhold Schmidt, MD, Stefan Ropele, PhD, Brigitte Rous, MD, 
Katja Petrovic, MagPsychol, Ulrike Garmehi, Alexandra Seewann, MD; Gabriele 
Schrotter, MD Lisboa, Portugal (Serviço de Neurologia, Centro de Estudos Egas 
Moniz, Hospital de Santa Maria): José M. Ferro, MD, PhD, Ana Verdelho, MD, Sofia 
Madureira, PsyD; Amsterdam, The Netherlands (Department of Radiology and 
Neurology, VU Medical Center): Philip Scheltens, MD, PhD, Ilse van Straaten, MD, 
Frederik Barkhof, MD, PhD, Alida Gouw, MSc, Wiesje van der Flier, PhD; 
Goteborg, Sweden (Institute of Clinical Neuroscience, Goteborg University): Anders 
Wallin, MD, PhD, Michael Jonsson, MD, Karin Lind, MD, Arto Nordlund, PsyD, 
Sindre Rolstad, PsyD, Ingela Isblad, RN; Huddinge, Sweden (Karolinska Institute, 
Neurotec Department, sektion of Clinical Geriatrics): Lars-Olof Wahlund, MD, PhD, 
Milita Crisby, MD, PhD, Anna Pettersson, physiotherapist, Kaarina Amberla, PsyD; 
Paris, France (Department of Neurology, Hopital Lariboisiere): Hugues Chabriat, 
MD, PhD, Karen Hernandez, psychologist, Annie Kurtz, psychologist, Dominique 
Hervé, MD; Mannheim, Germany (Department of Neurology, University of 
Heidelberg, Klinikum Mannheim): Michael Hennerici, MD, Christian Blahak, MD, 
Hansjorg Baezner, MD, Martin Wiarda, PsyD, Susanne Seip, RN; Copenhagen, 
Denmark (The Memory Disorders Research Group, Department of Neurology, 
Rigshospitalet, Copenhagen University Hospital, Denmark): Gunhild Waldemar, MD, 
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DMSc, Egill Rostrup, MD, MSc; Charlotte Ryberg, MSc, Tim Dyrby MSc, Olaf B. 
Paulson, MD, DMSc; Newcastle-upon-Tyne, UK (Institute for Ageing and Health, 
University of Newcastle): John O'Brien, DM, Sanjeet Pakrasi, MD, Andrew 
Teodorczuk, MRCPsych, Mani Krishnan MRCPsych, Michael Firbank, PhD, Philip 
English, DCR. 
The Coordinating centre is in Florence, Italy (Department of Neurological and 
Psychiatric Sciences, University of Florence): Domenico Inzitari, MD (Study 
Coordinator); Luciano Bartolini, PhD, Anna Maria Basile, MD, PhD, Eliana Magnani, 
MD, Monica Martini, MD, Mario Mascalchi, MD, PhD, Marco Moretti, MD, 
Leonardo Pantoni, MD, PhD, Anna Poggesi, MD, Giovanni Pracucci, MD, Emilia 
Salvadori, PhD, Michela Simoni, MD. 
The LADIS Steering Committee is formed by Domenico Inzitari, MD (study 
coordinator), Timo Erkinjuntti, MD, PhD, Philip Scheltens, MD, PhD, Marieke 
Visser, MD, PhD, and Peter Langhorne, MD, BSC, PhD, FRCP who replaced in this 
role Kjell Asplund, MD, PhD beginning with 2005. 
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TABLES 
 
Table 1.  Characteristics for the study group who completed all final year assessments.  
         
Number of subjects 399 
Age at inclusion 73.6  (5) 
Sex F:M 217:182 
GDS at inclusion: median (range)  2 (0-14) 
Incident depression: Number (%) 85 (21 %) 
Transition to disability over 3 years: Number (%) 95 (24%) 
History of depression: Number (%) 105 (26 %) 
History of hypertension: Number (%) 279 (70 %) 
History of stroke: Number (%) 110 (28 %) 
Years of education 10  (4) 
MMSE at inclusion 27.8 (2.2) 
DAD at inclusion 98.4 (6.4) 
ARWMC volume in ml: median (range) 13.3 ( 1 – 156 )  
         
Data are mean (SD) unless otherwise specified.  
Data obtained in subjects at baseline.  
GDS, Geriatric Depression Scale; MMSE, Mini Mental State Exam; ARWMC, age related white matter changes; 
DAD, Disability Assessment in Dementia Scale. 
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Table 2 Disability in Dementia scores over the study period 
      
Year 
 
DAD score 
 
Baseline 98.4 (6.4) 
1 97.7 (7.3) 
2  96.5 (11.1) 
3 93.9 (16.3) 
      
Data are mean (SD) 
DAD, Disability Assessment in Dementia Scale 
Data obtained in 383 subjects.  
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Table 3 Step forward regression analysis of predictors of quintile of GDS at 2 years (N=399) 
            
 
 
Univariate 
Analysis 
 
Multivariate 
Analysis 
 
        Rho 
 
P Value 
 
        OR 
 
P Value 
 
Baseline log ARWMC volume  0.27  <0.001*      1.54 (1.29 – 1.86) 0.001* 
Baseline GDS Quintile 0.64 <0.001* 3.15 (2.2 – 3.3) <0.001* 
Baseline MMSE -0.16   0.002*    1.0 (0.92 – 1.10) 0.9 
Years of education -0.20 <0.001* 0.96 ( 0.91 – 1.01) 0.15 
Age in years at inclusion 0.07  0.15   
Smoking (never vs. current/past) -0.05 0.3   
Baseline history of hypertension 0.06 0.2   
Baseline history of Stroke 0.05  0.3   
Sex -0.07  0.2   
            
Data obtained in 399 subjects.  
GDS, Geriatric Depression Scale; MMSE, Mini Mental State Exam; ARWMC, age related white matter changes. 
*p<0.05 
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Table 4.  Stepforward regression analysis of predictors of quintile GDS at 3 years (N=399) 
            
 
 
Univariate 
Analysis 
Multivariate 
Analysis 
 
        Rho 
 
P Value 
 
        OR 
 
P Value 
 
Baseline log ARWMC volume  0.16 0.001* 1.24 (1.04 – 1.48) 0.015* 
Baseline GDS Quintile 0.58 <0.001* 2.55 (2.15-3.02) <0.001* 
Years of education -0.1  0.023* 1.01 (0.96-1.06) 0.8 
Baseline MMSE -0.1 0.048* 1.02 (0.94 – 1.12) 0.6 
Sex -0.12 0.013 *  1.38 (0.95-2.00) 0.09 
Smoking (never vs. current/past) -0.03 0.6   
Baseline history of hypertension 0.01 0.9   
Baseline history of stroke 0.04 0.4   
Age in years at inclusion 0.09 0.08   
             
Data obtained in 399 subjects.  
GDS, Geriatric Depression Scale; MMSE, Mini Mental State Exam; ARWMC, age related white matter changes. 
*p<0.05 
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Table 5 – Stepforward regression analysis of predictors of incident depression over 3 years 
(n=399) 
            
 
 
Univariate 
Analysis 
Binary Regression 
Analysis 
 
        Rho 
 
P Value 
 
        OR 
 
P Value 
 
Baseline log ARWMC volume  0.099 0.047 * 1.36 (1.04-1.76) 0.02* 
Baseline history of depression 0.342 <0.001 * 5.42 (3.13 – 9.38) <0.001* 
Baseline MMSE -0.098 0.051 0.97 (0.87 – 1.08) 0.6 
Sex -0.096 0.057 0.76 (0.44-1.32) 0.3 
Years of education -0.036 0.5   
Smoking (never vs. current/past) -0.035 0.5   
Baseline history of hypertension -0.021 0.7   
Baseline history of stroke -0.047 0.3   
Age in years at inclusion 0.035 0.5   
            
Data obtained in 399 subjects.  
GDS, Geriatric Depression Scale; MMSE, Mini Mental State Exam; ARWMC, age related white matter changes. 
*p<0.05 
 
 
